Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Tax Provisions of $545000.0 for Q1 2026, up 445.0% year-over-year from $100000.0 in Q1 2025, and up 1858.06% quarter-over-quarter from -$31000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 5 years of Tax Provisions data on file, last reported at $545000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $545000.0, up 445.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $925000.0 (up 311.11% YoY), and the FY2025 annual result was $497000.0, up 43.64% from the prior year.
- Tax Provisions rose to $545000.0 in Q1 2026 per RYTM's latest filing, from -$31000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $545000.0 in Q1 2026 and troughed at -$300000.0 in Q3 2024.
- A 4-year average of $183090.9 and a median of $196000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2026: Tax Provisions sank 181.52% in 2024, then jumped 445.0% in 2026.
- A 4-year view of Tax Provisions shows it stood at $196000.0 in 2023, then sank by 127.55% to -$54000.0 in 2024, then surged by 42.59% to -$31000.0 in 2025, then soared by 1858.06% to $545000.0 in 2026.
- Business Quant data shows RYTM's Tax Provisions at $545000.0 in Q1 2026, -$31000.0 in Q4 2025, and $111000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | 545,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -300,000.00 |
| Jun 30, 2024 | 479,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | 368,000.00 |
| Sep 30, 2021 | -9.00 Mn |
| Jun 30, 2021 | -5.02 Mn |
| Mar 31, 2021 | 22.01 Mn |